Poland
# |
Name |
Current Liabilities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 955.01 M
|
Dec. 31, 2023 | USD 208.13 | 0.81% |
|
Poland |
|
2 |
USD 41.99 M
|
Dec. 31, 2023 | USD 0.90 | -1.27% |
|
Poland |
|
3 |
USD 35.29 M
|
Sept. 30, 2024 | USD 58.16 | 0.74% |
|
Poland |
|
4 |
USD 34.43 M
|
Dec. 31, 2023 | USD 5.15 | -3.61% |
|
Poland |
|
5 |
USD 31.04 M
|
Dec. 31, 2023 | USD 2.85 | 0.09% |
|
Poland |
|
6 |
USD 28.48 M
|
Dec. 31, 2023 | USD 36.63 | -0.24% |
|
Poland |
|
7 |
USD 27.53 M
|
Dec. 31, 2023 | USD 0.46 | 18.70% |
|
Poland |
|
8 |
USD 23.78 M
|
Dec. 31, 2023 | USD 10.78 | -0.36% |
|
Poland |
|
9 |
USD 21.89 M
|
Dec. 31, 2023 | USD 5.95 | -0.32% |
|
Poland |
|
10 |
USD 17.68 M
|
Dec. 31, 2023 | USD 6.78 | -1.52% |
|
Poland |
|
11 |
USD 14.03 M
|
Dec. 31, 2023 | USD 2.29 | -0.01% |
|
Poland |
|
12 |
USD 7.86 M
|
Dec. 31, 2023 | USD 1.23 | 1.32% |
|
Poland |
|
13 |
USD 6.78 M
|
Dec. 31, 2023 | USD 12.77 | 1.67% |
|
Poland |
|
14 |
USD 4.69 M
|
Dec. 31, 2023 | USD 9.53 | -0.94% |
|
Poland |
|
15 |
USD 3.12 M
|
Dec. 31, 2023 | USD 5.86 | 3.96% |
|
Poland |
|
16 |
USD 1.56 M
|
Dec. 31, 2023 | USD 40.34 | 2.10% |
|
Poland |
|
17 |
USD 797.29 K
|
Dec. 31, 2023 | USD 1.78 | -1.14% |
|
Poland |
|
18 |
USD 542.53 K
|
Dec. 31, 2023 | USD 21.83 | 2.30% |
|
Poland |
|
19 |
USD 293.15 K
|
Dec. 31, 2023 | USD 1.88 | 0.22% |
|
Poland |
The Healthcare company in Poland with the highest Current Liabilities is NEUCA S.A. (Warsaw Stock Exchange: NEU.WA) at USD 955.01 M.
The Healthcare company in Poland with the lowest Current Liabilities is Medinice S.A. (Warsaw Stock Exchange: ICE.WA) at USD 293.15 K.
The top 10 Healthcare companies in Poland by Current Liabilities are NEUCA S.A., BIOTON S.A., Synektik Spólka Akcyjna, Centrum Medyczne ENEL-MED S.A., EMC Instytut Medyczny SA, Voxel S.A., Europejskie Centrum Odszkodowan S.A., Selvita S.A., Celon Pharma S.A. and Ryvu Therapeutics S.A..
The bottom 10 Healthcare companies in Poland by Current Liabilities are Medinice S.A., Bioceltix S.A., Genomtec S.A., Scope Fluidics S.A., Medicalgorithmics S.A., Poltreg S.A., Captor Therapeutics Spolka Akcyjna, Synthaverse S.A., Mabion S.A. and Ryvu Therapeutics S.A..